Modeling how viral RNA behaves in cells
Official title: Predictive modeling of viral RNA cellular behavior
Funded at Scripps Research Institute, the · NIH-10923737 · Data updated 2026-11-12
This study is looking at how the HIV virus behaves inside cells to help find better treatments for people living with HIV by understanding how its RNA interacts with proteins.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 18, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $460,000 |
| NIH project number | 1DP5OD037420-01 |
| Project ID | NIH-10923737 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV or those at risk of HIV infection.
✕Less likely to help
Patients who are not affected by HIV or do not have any viral infections may not benefit from this research.
What this research studies
This research investigates the dynamic behavior of viral RNA within cells, specifically focusing on the HIV virus. By utilizing advanced technologies to measure RNA interactions and dynamics, the project aims to create predictive models that can inform drug-targeting strategies. The approach involves studying the interactions between HIV RNA and proteins to understand how these dynamics influence viral functions. Patients may benefit from insights gained that could lead to new treatments for HIV.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies for HIV by improving our understanding of viral RNA behavior.
How similar studies have gone: Previous research has shown promise in using similar modeling approaches to understand viral behavior, indicating potential for success in this area.
Where this research is happening
-
Scripps Research Institute, the
La Jolla, United States Active
Researchers
- Principal investigator: Ken, Megan L — Scripps Research Institute, the
- Study coordinator: Ken, Megan L
Related research
Other NIH-funded projects on the same topics.
-
The Participant Center helps people join and stay in a nationwide health study
A nationwide program to support people in joining, contributing biosamples, and staying connected to a large health study in the United States.
-
Data Sharing and Bioinformatics Core for Viral Systems Biology
A center-led effort to manage, share, and interpret large viral systems biology data using open tools and a community-friendly portal.
-
Germline-targeted HIV vaccines using membrane liposome tech to trigger bnAbs
A new HIV vaccine approach aims to spark broadly neutralizing antibodies by showing MPER on membranes, tested in models and early studies to guide future human trials.
-
Antivirals for hemorrhagic fever viruses like LASV, SFTSV, and EBOV
A multi-institutional effort to find and validate antiviral compounds that block key viral proteins from LASV, SFTSV, and EBOV to help people at risk from serious hemorrhagic fevers.
-
Developing new antivirals for flaviviruses
A research team is working to create oral antiviral drugs targeting flaviviruses to treat infections that affect millions of people.
-
CoV inhibitors targeting non-enzymatic SARS-CoV-2 components
A multicenter research effort seeks antiviral ideas that block SARS-CoV-2 parts that don’t work through traditional enzymes, aiming to help people affected by COVID-19.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.